- Home
- CNMD vs APGE Comparison
CNMD vs APGE Comparison
Compare CNMD & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- APGE
- Stock Information
- Founded
- CNMD 1970
- APGE 2022
- Country
- CNMD United States
- APGE United States
- Employees
- CNMD N/A
- APGE N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNMD Health Care
- APGE Health Care
- Exchange
- CNMD Nasdaq
- APGE Nasdaq
- Market Cap
- CNMD 1.7B
- APGE 2.1B
- IPO Year
- CNMD 1987
- APGE 2023
- Fundamental
- Price
- CNMD $56.94
- APGE $37.08
- Analyst Decision
- CNMD Buy
- APGE Strong Buy
- Analyst Count
- CNMD 5
- APGE 4
- Target Price
- CNMD $62.20
- APGE $91.33
- AVG Volume (30 Days)
- CNMD 311.9K
- APGE 592.7K
- Earning Date
- CNMD 07-30-2025
- APGE 05-12-2025
- Dividend Yield
- CNMD 1.41%
- APGE N/A
- EPS Growth
- CNMD 46.38
- APGE N/A
- EPS
- CNMD 3.81
- APGE N/A
- Revenue
- CNMD $1,315,998,000.00
- APGE N/A
- Revenue This Year
- CNMD $6.27
- APGE N/A
- Revenue Next Year
- CNMD $5.62
- APGE $743.14
- P/E Ratio
- CNMD $14.93
- APGE N/A
- Revenue Growth
- CNMD 4.32
- APGE N/A
- 52 Week Low
- CNMD $46.00
- APGE $26.20
- 52 Week High
- CNMD $78.58
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- CNMD 50.54
- APGE 46.89
- Support Level
- CNMD $54.77
- APGE $35.71
- Resistance Level
- CNMD $58.27
- APGE $38.04
- Average True Range (ATR)
- CNMD 1.63
- APGE 1.96
- MACD
- CNMD -0.31
- APGE -0.46
- Stochastic Oscillator
- CNMD 38.14
- APGE 21.99
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.